Celularity Inc
NASDAQ:CELU

Watchlist Manager
Celularity Inc Logo
Celularity Inc
NASDAQ:CELU
Watchlist
Price: 1.6 USD -4.19% Market Closed
Market Cap: 45.3m USD

Net Margin
Celularity Inc

-198.9%
Current
-302%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-198.9%
=
Net Income
-80.7m
/
Revenue
40.6m

Net Margin Across Competitors

No Stocks Found

Celularity Inc
Glance View

Market Cap
45.1m USD
Industry
Biotechnology

Celularity, Inc. a clinical stage biotechnology company, discovers cancer sub-types and therapeutic options for cancer patients in the United States. The company is headquartered in New York City, New York and currently employs 225 full-time employees. The company went IPO on 2019-05-23. The company operates through three business segments: Cell Therapy, Degenerative Disease, and BioBanking. Its therapy product candidates include T cells engineered with a chimeric antigen receptor (CAR), unmodified and genetically modified natural killer (NK) cells, mesenchymal-like adherent stromal cells (ASCs), and targeting therapeutic candidates target indications across cancer, infectious and degenerative diseases. Its cell therapeutic programs include CyCART-19 is a placental-derived CAR-T cell therapy and targeting the CD19 receptor; CYNK-001 is for the treatment of acute myeloid leukemia (AML); CYNK-101 is genetically modified version of a placental-derived NK-cell; APPL-001 developed for the treatment of Crohn’s disease, a degenerative disease, and PDA-002 developed for the treatment of Facioscapulohumeral muscular dystrophy (FSHD).

CELU Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-198.9%
=
Net Income
-80.7m
/
Revenue
40.6m
What is the Net Margin of Celularity Inc?

Based on Celularity Inc's most recent financial statements, the company has Net Margin of -198.9%.

Back to Top